Medicare Enrolled
Dr. Wayne Kotzker, MD
Nephrology · Fort Lauderdale, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kotzker from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kotzker?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kotzker
Dr. Wayne Kotzker is a nephrology specialist in Fort Lauderdale, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Kotzker performed 3,500 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Kotzker received a total of $334,978 from 41 pharmaceutical and/or device companies across 904 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kotzker is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 11% volume in FL
$334,978 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗3,500
Medicare services
Top 11% in FL for nephrology
Not available
Unique patients (not deduplicated)
$90
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
929 | $64 | $156 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
878 | $67 | $248 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
298 | $99 | $234 |
| Dialysis services for patients 20 or older Dialysis treatment provided to patients aged 20 years or older, involving four or more physician visits per month. |
261 | $286 | $688 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
216 | $142 | $342 |
| Dialysis services, partial month (age 20+) Dialysis treatment provided for a partial month of service for patients aged 20 years or older. |
193 | $8 | $18 |
| Home dialysis services per month Monthly dialysis treatment provided in the patient's home for individuals aged 20 or older. |
117 | $234 | $572 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
75 | $120 | $326 |
| Creatinine test (kidney function) A blood test that measures the amount of creatinine to assess kidney function or detect muscle injury. |
57 | $5 | $10 |
| Urine total protein level A laboratory test that measures the total amount of protein present in a urine sample. |
41 | $4 | $8 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
40 | $3 | $6 |
| Phosphate level test A blood test that measures the amount of phosphate in your body. Phosphate is a mineral that helps keep bones and teeth strong. |
40 | $5 | $10 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
39 | $8 | $16 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
33 | $10 | $22 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
31 | $4 | $10 |
| Urine microalbumin test (kidney screening) A laboratory test that measures the amount of microalbumin, a small protein, in a urine sample. This test is used to detect early signs of kidney damage. |
29 | $6 | $12 |
| Dialysis services for adults, 2-3 visits per month This code covers dialysis services for patients aged 20 or older who have 2 to 3 physician visits per month. |
28 | $243 | $572 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
25 | $61 | $176 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
24 | $7 | $14 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
24 | $94 | $258 |
| Parathyroid hormone level test A blood test that measures the amount of parathyroid hormone in your body. This hormone helps regulate calcium levels in the blood and bones. |
20 | $40 | $82 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
20 | $118 | $394 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
19 | $94 | $348 |
| Extensive in-home visit for existing patient post-discharge A comprehensive home visit lasting 75 minutes for an existing patient after hospital discharge. This service is available only within Medicare-approved CMMI models and must occur in the patient's residence or care facility within 90 days. |
19 | $174 | $410 |
| Hemodialysis, single evaluation A dialysis procedure to filter waste from the blood, performed with a physician's evaluation. |
16 | $60 | $140 |
| Kidney function blood test panel | 15 | $9 | $18 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
13 | $92 | $534 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$334,978
Total received (2018-2024)
Avg $47,854/year across 7 years
Top 1% in FL for nephrology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
904
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$111,710
2023
$95,013
2022
$70,556
2021
$16,913
2020
$17,934
2019
$21,359
2018
$1,494
Payments by company (2024)
Travere Therapeutics, Inc.
$25,384
Amgen Inc.
$23,736
Bayer Healthcare Pharmaceuticals Inc.
$19,016
Boehringer Ingelheim Pharmaceuticals, Inc.
$11,151
Lilly USA, LLC
$8,489
AstraZeneca Pharmaceuticals LP
$7,892
Ardelyx, Inc.
$7,459
GlaxoSmithKline, LLC.
$4,762
CALLIDITAS THERAPEUTICS US INC.
$3,057
Mallinckrodt Hospital Products Inc.
$165
Novartis Pharmaceuticals Corporation
$165
Aurinia Pharma U.S., Inc.
$115
Otsuka America Pharmaceutical, Inc.
$64
ANI Pharmaceuticals, Inc.
$56
Novo Nordisk Inc
$54
Alexion Pharmaceuticals, Inc.
$45
AKEBIA THERAPEUTICS INC
$39
Vifor Pharma, Inc.
$32
OPKO Pharmaceuticals, LLC
$16
Fresenius USA Marketing, Inc.
$13
Top 3 companies account for 61.0% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$81,669
Horizon Therapeutics plc
$46,738
Bayer HealthCare Pharmaceuticals Inc.
$42,562
Travere Therapeutics, Inc.
$37,459
Bayer Healthcare Pharmaceuticals Inc.
$33,796
Amgen Inc.
$24,633
GlaxoSmithKline, LLC.
$15,998
Boehringer Ingelheim Pharmaceuticals, Inc.
$11,217
Otsuka America Pharmaceutical, Inc.
$10,788
Lilly USA, LLC
$8,489
Ardelyx, Inc.
$7,459
Retrophin, Inc.
$4,148
CALLIDITAS THERAPEUTICS US INC.
$3,100
OPKO Pharmaceuticals, LLC
$2,319
BAXTER HEALTHCARE
$512
Mallinckrodt Hospital Products Inc.
$511
Novo Nordisk AS
$400
Janssen Pharmaceuticals, Inc
$375
AKEBIA THERAPEUTICS INC
$333
Novo Nordisk Inc
$294
Novartis Pharmaceuticals Corporation
$239
Relypsa, Inc.
$180
Aurinia Pharma U.S., Inc.
$180
Vifor Pharma, Inc.
$177
La Jolla Pharmaceutical Company
$167
Bard Peripheral Vascular, Inc.
$155
Esperion Therapeutics, Inc.
$131
PFIZER INC.
$125
Shire North American Group Inc
$122
Keryx Biopharmaceuticals, Inc.
$121
Mallinckrodt Enterprises LLC
$121
Alexion Pharmaceuticals, Inc.
$103
Fresenius USA Marketing, Inc.
$103
Mallinckrodt LLC
$68
ANI Pharmaceuticals, Inc.
$56
Medtronic, Inc.
$27
Avion Pharmaceuticals
$27
Takeda Pharmaceuticals U.S.A., Inc.
$21
Ultragenyx Pharmaceutical Inc.
$21
Cumberland Pharmaceuticals, Inc.
$18
ARBOR PHARMACEUTICALS, INC.
$16
Top 3 companies account for 51.0% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AURYXIA · Aranesp · Auryxia · BENLYSTA · BRILINTA · Balcoltra · ELIQUIS · ELLIPSYS VASCULAR ACCESS SYSTEM · ENTRESTO · Edarbi · FARXIGA · Fabhalta · GATTEX · GIAPREZA · IBSRELA · JARDIANCE · JESDUVROQ · JYNARQUE · KRYSTEXXA · Kerendia · Korsuva · LOKELMA · LUPKYNIS · LUTONIX · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · Non-Covered · Ozempic · PURIFIED CORTROPHIN GEL · Parsabiv · RAYALDEE · RYBELSUS · Rayaldee · Renal - PD · Repatha · SAMSCA · SOLIRIS · TARPEYO · TAVNEOS · TERLIVAZ · Tavneos · ULTOMIRIS · Vafseo · Vaprisol Dextrose in Plastic Container · Velphoro · Veltassa · Wegovy · XARELTO · XPHOZAH 30 MG
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Nephrologists in nearby ZIP areas
141
County median income
$74,534
Nearest hospital to ZIP centroid (approximate)
BROWARD HEALTH MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kotzker is a clinical cardiology specialist, with above-average Medicare volume (top 11% in FL), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kotzker experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Kotzker performed 929 hospital follow-up visit, moderate complexity services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Kotzker receive payments from pharmaceutical companies?
Yes. Dr. Kotzker received a total of $334,978 from 41 companies across 904 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kotzker's costs compare to other nephrologists in Fort Lauderdale?
Dr. Kotzker's average Medicare payment per service is $90. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kotzker) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Nephrology
Common procedures, typical costs, and what industry payments mean in nephrology.
Same specialty & city
Nephrologists in Fort Lauderdale
Browse nephrologists in Fort Lauderdale ranked by procedure volume and transparency data.
Highest volume
Top Nephrologists in FL
Nephrologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Nephrologists in FL
Which FL nephrologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Horizon Therapeutics plc Payments to Doctors
See all physicians who received payments from Horizon Therapeutics plc.
By company
Bayer HealthCare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer HealthCare Pharmaceuticals Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology